BioMend Extend, REF# 0142Z, Synthetic bone grafting material.
FDA Device Recall #Z-0414-2019 — Class III — August 16, 2018
Recall Summary
| Recall Number | Z-0414-2019 |
| Classification | Class III — Low risk |
| Date Initiated | August 16, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Collagen Matrix, Inc. |
| Location | Allendale, NJ |
| Product Type | Devices |
| Quantity | 569 |
Product Description
BioMend Extend, REF# 0142Z, Synthetic bone grafting material.
Reason for Recall
There is a possibility that the product was packaged in the wrong box. Specifically, the product may have been placed inside a BioMend box instead of a BioMend Extend box. The only difference between the two boxes is the product trade name. The label placed on the box and on the product packaged inside the box is correct. The Instructions for Use inside the box are correct.
Distribution Pattern
Distributed to one distributor located in Florida.
Lot / Code Information
CDMEN18F1, CDMEN18F3
Other Recalls from Collagen Matrix, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0668-2022 | Class II | DuraMatrix-Onlay Collagen Dura Substitute Memb... | Dec 13, 2021 |
| Z-0669-2022 | Class II | RESODURA matrix onlay 10.0 cm x 12.5 cm - indic... | Dec 13, 2021 |
| Z-1389-2019 | Class II | Neomem Resorbable Collagen Membrane, 15 mm x 20... | Mar 19, 2019 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.